PC
SPPI

PointState Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

PointState Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-115,550
Closed -$790K – 148
2015
Q2 		$790K Buy
+115,550
New +$734K 0.01% 142
2013
Q4 		– Sell
-1,000,000
Closed -$8.38M – 183
2013
Q3 		$8.38M Buy
1,000,000
+350,000
+54% +$2.83M 0.14% 85
2013
Q2 		$4.85M Buy
+650,000
New +$4.99M 0.08% 106

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PointState Capital's SPPI Position: Q3 2015 in Review

PointState Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2015, closing a stake of 115,550 shares — an estimated $790K sold.

PointState Capital first reported a position in SPPI in Q2 2013 and held it in 3 quarters. The position peaked at $8.38M in Q3 2013. 148 funds tracked by Wall St. Rank hold SPPI as of Q3 2015.

  • PointState Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • PointState Capital sold 115,550 Spectrum Pharmaceuticals Inc shares in Q3 2015, an estimated $790K.
  • PointState Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • PointState Capital's Spectrum Pharmaceuticals Inc position peaked at $8.38M in Q3 2013.
  • 148 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2015.

Based on PointState Capital's 13F filing for Q3 2015, filed 16 Nov 2015.